Focus on PD-1/PD-L1 as a Therapeutic Target in Ovarian Cancer

Ovarian cancer is considered one of the most aggressive and deadliest gynecological malignancies worldwide. Unfortunately, the therapeutic methods that are considered the gold standard at this moment are associated with frequent recurrences. Survival in ovarian cancer is associated with the presence...

Descripción completa

Detalles Bibliográficos
Autores principales: Dumitru, Adrian, Dobrica, Elena-Codruta, Croitoru, Adina, Cretoiu, Sanda Maria, Gaspar, Bogdan Severus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603705/
https://www.ncbi.nlm.nih.gov/pubmed/36292922
http://dx.doi.org/10.3390/ijms232012067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603705/
https://www.ncbi.nlm.nih.gov/pubmed/36292922
http://dx.doi.org/10.3390/ijms232012067

Ejemplares similares